logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Ksenija Nesic

walter and eliza hall institute of medical research
H指数:7
被引数:615

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2 EMBRACE trial

奥拉帕利在HR缺陷、转移性三阴性乳腺癌和铂敏感复发性卵巢癌中BRCA1/2无胚系突变患者中的疗效：EMBRACE二期临床试验

British Journal of Cancer
IF6.8
2026-07-080
OA
Katrin M. Sjoquist; Alexander Dobrovic; Kristy P. Robledo; Ksenija Nesic; Sally Baron-Hay; Sumitra Ananda; Nicole McCarthy; Jeffrey Goh; Christopher Steer; Nick Murray; Sonia Yip; Linda R. Mileshkin; J. Lynn Fink; Garry Chang; Lisa Bailey; Yvonne Lee; Danka S. Zebic; U. G. Imalki U. Kariyawasam; Kristy Shield-Artin; Andrew Jarratt; Justin Bedő; Anthony T. Papenfuss; Olga Kondrashova; Matthew J. Wakefield; Cassandra J. Vandenberg; Martin R. Stockler; Clare L. Scott; Paul M. Waring
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial

奥拉帕利、度伐利尤单抗和环磷酰胺，以及铂敏感卵巢癌的预后血液特征：随机Ⅱ期SOLACE2试验

Nature Communications
IF15.7
2025-11-050
OA
Chee Khoon Lee; Apriliana E. R. Kartikasari; Nirashaa T. Bound; Katherine E. Francis; Kristy Shield-Artin; Justin Bedo; Ksenija Nesic; Katrina Diamante; Rachel L. O’Connell; Mutsa Madondo; Momodou Cox; Claire Davies; Cyril Deceneux; Georgia Goodchild; Andrew Jarratt; Emily Cassar; Hina Amer; U. G. Imalki U. Kariyawasam; Yeh Chen Lee; Janine Lombard; Sally Baron-Hay; Yoland Antill; Catherine Shannon; Sudarshan Selva-Nayagam; Philip Beale; Danka Zebic; Sandy Simon; Anneliese Linaker; Michael A. Quinn; Anthony T. Papenfuss; Matthew J. Wakefield; Cassandra J. Vandenberg; Michael Friedlander; Clare L. Scott; Magdalena Plebanski
Farletuzumab ecteribulin and MORAb-109, folate receptor alpha and mesothelin targeting antibody-drug conjugates, show activity in poor prognosis gynaecological cancer models

Farletuzumab ecteribulin和MORAb-109，靶向叶酸受体α和间皮素的抗体-药物偶联物，在预后不良的妇科癌症模型中显示出活性。

CLINICAL AND TRANSLATIONAL MEDICINE
IF6.8
2025-03-120
OA
Nesic, Ksenija; Rybinski, Katherine; Ratnayake, Gayanie; Ho, Gwo-Yaw; Lim, Ratana; Radke, Marc; Neagle, Chloe; Swisher, Elizabeth M.; Wakefield, Matthew J.; Barker, Holly E.; Furuuchi, Keiji; Scott, Clare L.; Vandenberg, Cassandra J.
The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models

微管抑制剂eribulin在铂耐药和难治性高级浆液性卵巢癌患者来源的异种移植模型中显示出疗效

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2023-11-221
OAAI
Ho, Gwo Yaw; Vandenberg, Cassandra J.; Lim, Ratana; Christie, Elizabeth L.; Garsed, Dale W.; Lieschke, Elizabeth; Nesic, Ksenija; Kondrashova, Olga; Ratnayake, Gayanie; Radke, Marc; Penington, Jocelyn S.; Carmagnac, Amandine; Heong, Valerie; Kyran, Elizabeth L.; Zhang, Fan; Traficante, Nadia; Huang, Ruby; Dobrovic, Alexander; Swisher, Elizabeth M.; McNally, Orla; Kee, Damien; Wakefield, Matthew J.; Papenfuss, Anthony T.; Bowtell, David D. L.; Barker, Holly E.; Scott, Clare L.
Targeting homologous recombination deficiency in uterine leiomyosarcoma

靶向子宫平滑肌肉瘤的同源重组缺陷

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
IF12.8
2023-05-0410
OAAI
Dall, Genevieve; Vandenberg, Cassandra J. J.; Nesic, Ksenija; Ratnayake, Gayanie; Zhu, Wenying; Vissers, Joseph H. A.; Bedo, Justin; Penington, Jocelyn; Wakefield, Matthew J. J.; Kee, Damien; Carmagnac, Amandine; Lim, Ratana; Shield-Artin, Kristy; Milesi, Briony; Lobley, Amanda; Kyran, Elizabeth L. L.; O'Grady, Emily; Tram, Joshua; Zhou, Warren; Nugawela, Devindee; Stewart, Kym Pham; Caldwell, Reece; Papadopoulos, Lia; Ng, Ashley P. P.; Dobrovic, Alexander; Fox, Stephen B. B.; McNally, Orla; Power, Jeremy D. D.; Meniawy, Tarek; Tan, Teng Han; Collins, Ian M. M.; Klein, Oliver; Barnett, Stephen; Olesen, Inger; Hamilton, Anne; Hofmann, Oliver; Grimmond, Sean; Papenfuss, Anthony T. T.; Scott, Clare L. L.; Barker, Holly E. E.
Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma
CANCER RESEARCH
IF16.6
2021-07-2860
OA
Nesic, Ksenija; Kondrashova, Olga; Hurley, Rachel M.; McGehee, Cordelia D.; Vandenberg, Cassandra J.; Ho, Gwo-Yaw; Lieschke, Elizabeth; Dall, Genevieve; Bound, Nirashaa; Shield-Artin, Kristy; Radke, Marc; Musafer, Ashan; Chai, Zi Qing; Ghamsari, Mohammad Reza Eftekhariyan; Harrell, Maria, I; Kee, Damien; Olesen, Inger; McNally, Orla; Traficante, Nadia; DeFazio, Anna; Bowtell, David D. L.; Swisher, Elizabeth M.; Weroha, S. John; Nones, Katia; Waddell, Nicola; Kaufmann, Scott H.; Dobrovic, Alexander; Wakefield, Matthew J.; Scott, Clare L.
Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance
NAR CANCER
IF3.2
2021-07-0923
OAAI
Hurley, Rachel M.; McGehee, Cordelia D.; Nesic, Ksenija; Correia, Cristina; Weiskittel, Taylor M.; Kelly, Rebecca L.; Venkatachalam, Annapoorna; Hou, Xiaonan; Pathoulas, Nicholas M.; Meng, X. Wei; Kondrashova, Olga; Radke, Marc R.; Schneider, Paula A.; Flatten, Karen S.; Peterson, Kevin L.; Becker, Marc A.; Wong, Ee Ming; Southey, Melissa S.; Dobrovic, Alexander; Lin, Kevin K.; Harding, Thomas C.; McNeish, Iain; Ross, Christian A.; Wagner, Jill M.; Wakefield, Matthew J.; Scott, Clare L.; Haluska, Paul; Hendrickson, Andrea E. Wahner; Karnitz, Larry M.; Swisher, Elizabeth M.; Li, Hu; Weroha, S. John; Kaufmann, Scott H.
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
NATURE COMMUNICATIONS
IF15.7
2018-09-28210
OAAI
Kondrashova, Olga; Topp, Monique; Nesic, Ksenija; Lieschke, Elizabeth; Ho, Gwo-Yaw; Harrell, Maria, I; Zapparoli, Giada, V; Hadley, Alison; Holian, Robert; Boehm, Emma; Heong, Valerie; Sanij, Elaine; Pearson, Richard B.; Krais, John J.; Johnson, Neil; McNally, Orla; Ananda, Sumitra; Alsop, Kathryn; Hutt, Karla J.; Kaufmann, Scott H.; Lin, Kevin K.; Harding, Thomas C.; Traficante, Nadia; deFazio, Anna; McNeish, Lain A.; Bowtell, David D.; Swisher, Elizabeth M.; Dobrovic, Alexander; Wakefield, Matthew J.; Scott, Clare L.; Chenevix-Trench, G.; Green, A.; Webb, P.; Gertig, D.; Fereday, S.; Moore, S.; Hung, J.; Harrap, K.; Sadkowsky, T.; Pandeya, N.; Malt, M.; Mellon, A.; Robertson, R.; Vanden Bergh, T.; Jones, M.; Mackenzie, P.; Maidens, J.; Nattress, K.; Chiew, Y. E.; Stenlake, A.; Sullivan, H.; Alexander, B.; Ashover, P.; Brown, S.; Corrish, T.; Green, L.; Jackman, L.; Ferguson, K.; Martin, K.; Martyn, A.; Ranieri, B.; White, J.; Jayde, V; Mamers, P.; Bowes, L.; Galletta, L.; Giles, D.; Hendley, J.; Schmidt, T.; Shirley, H.; Ball, C.; Young, C.; Viduka, S.; Tran, H.; Bilic, S.; Glavinas, L.; Brooks, J.; Stuart-Harris, R.; Kirsten, F.; Rutovitz, J.; Clingan, P.; Glasgow, A.; Proietto, A.; Braye, S.; Otton, G.; Shannon, J.; Bonaventura, T.; Stewart, J.; Begbie, S.; Friedlander, M.; Bell, D.; Baron-Hay, S.; Ferrier, A.; Gard, G.; Nevell, D.; Pavlakis, N.; Valmadre, S.; Young, B.; Camaris, C.; Crouch, R.; Edwards, L.; Hacker, N.; Marsden, D.; Robertson, G.; Beale, P.; Beith, J.; Carter, J.; Dalrymple, C.; Houghton, R.; Russell, P.; Links, M.; Grygiel, J.; Hill, J.; Brand, A.; Byth, K.; Jaworski, R.; Harnett, P.; Sharma, R.; Wain, G.; Ward, B.; Papadimos, D.; Crandon, A.; Cummings, M.; Horwood, K.; Obermair, A.; Perrin, L.; Wyld, D.; Nicklin, J.; Davy, M.; Oehler, M. K.; Hall, C.; Dodd, T.; Healy, T.; Pittman, K.; Henderson, D.; Miller, J.; Pierdes, J.; Blomfield, P.; Challis, D.; Mclntosh, R.; Parker, A.; Brown, B.; Rome, R.; Allen, D.; Grant, P.; Hyde, S.; Laurie, R.; Robbie, M.; Healy, D.; Jobling, T.; Manolitsas, T.; McNealage, J.; Rogers, P.; Susil, B.; Sumithran, E.; Simpson, I; Phillips, K.; Rischin, D.; Fox, S.; Johnson, D.; Lade, S.; Loughrey, M.; O'Callaghan, N.; Murray, W.; Waring, P.; Billson, V; Pyman, J.; Neesham, D.; Quinn, M.; Underhill, C.; Bell, R.; Ng, L. F.; Blum, R.; Ganju, V; Hammond, I; Leung, Y.; McCartney, A.; Buck, M.; Haviv, I; Purdie, D.; Whiteman, D.; Zeps, N.
Loss of RAD51C promoter hypermethylation confers PARP inhibitor resistance
CANCER RESEARCH
IF16.6
2018-07-011
PRE
Hurley, Rachel M.; Nesic, Ksenija; McGehee, Cordelia; Kondrashova, Olga; Harrell, Maria I.; Schneider, Paula A.; Hou, Xiaonan; Correia, Cristina; Flatten, Karen S.; Zapparoli, Giada V.; Dobrovic, Alexander; Lin, Kevin K.; Harding, Thomas C.; Hendrickson, Andrea E. Wahner; Swisher, Elizabeth M.; Wakefield, Matthew; Weroha, S. John; Scott, Clare L.; Kaufmann, Scott H.

研究方向

暂未获取到该数据
M
Matthew J. Wakefield
H 指数:39论文数:236被引数:1.4万
C
Clare L. Scott
H 指数:81论文数:505被引数:3.8万
O
Olga Kondrashova
H 指数:22论文数:155被引数:2,821
C
Cassandra J. Vandenberg
H 指数:24论文数:101被引数:3,912
E
Elizabeth M. Swisher
H 指数:103论文数:743被引数:6.6万
M
Marc R. Radke
H 指数:18论文数:114被引数:1,488
G
Gwo‐Yaw Ho
H 指数:15论文数:80被引数:1,783
K
Kristy Shield‐Artin
H 指数:10论文数:38被引数:1,408
A
Alexander Dobrovic
H 指数:67论文数:437被引数:1.8万
K
Kevin Lin
H 指数:75论文数:836被引数:2.7万